CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 | ||
| 2023-06-09 | Bitterman Kevin Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 | ||
| 2023-06-09 | White William Richard Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 | ||
| 2023-06-09 | Ashiya Mona Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 | ||
| 2023-02-15 | AI DMI LLC 10% owner | Purchase | +434,783 | $23.00 | $10.0M | 3,141,759 |
| 2023-02-15 | Ashiya Mona Director | Purchase | +57,318 | $23.00 | $1.3M | 1,196,825 |
| 2023-02-15 | Ashiya Mona Director | Purchase | +37,049 | $23.00 | $852K | 773,607 |
| 2023-02-15 | Ashiya Mona Director | Purchase | +14,329 | $23.00 | $330K | 299,205 |
| 2023-02-15 | ORBIMED ADVISORS LLC Director | Purchase | +57,318 | $23.00 | $1.3M | 1,196,825 |
| 2023-02-15 | ORBIMED ADVISORS LLC Director | Purchase | +37,049 | $23.00 | $852K | 773,607 |
| 2023-02-15 | ORBIMED ADVISORS LLC Director | Purchase | +14,329 | $23.00 | $330K | 299,205 |
| 2022-12-29 | Atlas Venture Fund X, L.P. 10% owner | Other acquisition | +1,835,799 | 2,237,303 | ||
| 2022-12-29 | Atlas Venture Fund X, L.P. 10% owner | Other acquisition | +882,224 | 955,156 | ||
| 2022-12-29 | ORBIMED ADVISORS LLC Director | Other acquisition | +284,876 | 284,876 | ||
| 2022-12-29 | ORBIMED ADVISORS LLC Director | Other acquisition | +582,622 | 582,622 | ||
| 2022-12-29 | ORBIMED ADVISORS LLC Director | Other acquisition | +153,936 | 736,558 | ||
| 2022-12-29 | ORBIMED ADVISORS LLC Director | Other acquisition | +1,139,507 | 1,139,507 | ||
| 2022-12-29 | Bitterman Kevin Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-12-29 | Ashiya Mona Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-12-29 | Nicholson Donald William Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 |
Page 31 of 32 · 639 trades